NeuroSAFE Prostate Surgery London
NeuroSAFE Prostate Surgery London
NeuroSAFE Prostate Surgery in London
With Professor Prasanna Sooriakumaran, a world-leading robotic prostate surgeon
Professor Prasanna Sooriakumaran
MA (Oxon) BMedSci (Hons) BMBS (Hons) PGCertMedLaw ADCertClinInv (Cornell)
FRCS (Urol) FEBU USMLE PhD
Robotic Prostatectomy with Professor Prasanna Sooriakumaran
Explaining robotic prostate cancer surgery, recovery and the benefits of advanced surgical precision.
Testimonials
Glen’s Prostate Cancer Treatment Story
A patient testimonial on diagnosis, surgery, recovery and ongoing aftercare with Professor Prasanna Sooriakumaran.
Book a Consultation
Arrange a consultation with Professor Prasanna Sooriakumaran for clear, specialist guidance on your diagnosis, results, or treatment options.
Book a Consultation
Arrange a consultation with Professor Prasanna Sooriakumaran for clear, specialist guidance on your diagnosis, results, or treatment options.
Excellent Google Reviews
Fees and Pricing
Clear, transparent pricing is an important part of planning your care. The following guide outlines consultation fees for patients considering NeuroSAFE as part of their robotic prostate cancer surgery.
Consultation Fees
Initial Consultation
£325
A detailed consultation to review your diagnosis, MRI findings, biopsy results, and overall health, and to determine whether NeuroSAFE may be appropriate as part of your robotic prostate surgery. Appointments are available in person in London or remotely via video or telephone.
Follow-Up Consultation
£225
Follow-up appointments are available to review any additional investigations, discuss your treatment plan, and provide further guidance on whether NeuroSAFE or other advanced surgical techniques may be appropriate.
NeuroSAFE Robotic Prostate Surgery
NeuroSAFE is not a standalone treatment but an advanced technique that may be incorporated into robotic prostate surgery where clinically appropriate and available.
Typical Cost
£23,000 – £25,000
Where NeuroSAFE forms part of your robotic prostate surgery, the overall cost will depend on the hospital where your procedure is performed and your individual treatment plan. A personalised quotation will be provided following your consultation, ensuring complete transparency before proceeding.
What to Expect
- Procedure length: Typically 2–3 hours
- Hospital stay: Typically 1–2 nights
- Timeframe of surgery: Usually within a few weeks, depending on individual circumstances
- Technique: Minimally invasive robotic prostate surgery, with NeuroSAFE utilised where clinically appropriate and available
Finance and Insurance
At Prostate Clinic London, we aim to ensure specialist prostate cancer care is both transparent and accessible. A range of payment options is available, and most major private medical insurers are accepted, with guidance provided to help you understand costs, coverage, and the options available to you. The focus is on ensuring the process is clear and supportive, so you can concentrate on your health and making informed decisions about your care.
Recognised Internationally for Excellence in Prostate Cancer Care
Professor Prasanna Sooriakumaran has received over 30 international awards recognising his contribution to urology and prostate cancer care, including a National Clinical Impact Award for excellence beyond standard clinical practice.
He is the only urologist worldwide to hold Visiting Professorships at both the University of Oxford and the All-India Institute of Medical Sciences, and has been named one of London’s most influential doctors. His work continues to shape modern approaches to prostate cancer surgery.
Ranked Among the UK’s Top 10 Prostate Cancer Surgeons
Experience plays a critical role in prostate cancer treatment, particularly when it comes to achieving the best possible outcomes. Surgical technique and specialist expertise can have a meaningful impact on cancer control, as well as functional outcomes such as continence and erectile function.
Professor Prasanna Sooriakumaran has been recognised among the leading prostate cancer surgeons in the UK, including being featured in the Daily Mail’s list of top prostate cancer surgeons. This recognition reflects both his experience and his commitment to delivering high-quality care for patients.
This level of expertise is an important factor for patients seeking private prostate cancer treatment in London.
Who May Be Suitable for NeuroSAFE?
NeuroSAFE is not required or appropriate for every patient undergoing robotic prostate cancer surgery. Whether the technique may be used depends on a careful assessment of your individual diagnosis, including the location and extent of the cancer, your MRI and biopsy findings, PSA level, and whether the neurovascular bundles can be safely preserved.
The availability of specialist frozen-section pathology at the hospital where your surgery is performed is also an important consideration. Professor Prasanna Sooriakumaran carefully assesses every patient to determine whether NeuroSAFE may form part of the most appropriate surgical approach for their individual circumstances.
London’s Most Influential Doctor by the Evening Standard
Professor Prasanna Sooriakumaran was the first surgeon at University College London Hospitals to perform Retzius-sparing robotic prostatectomy, an advanced technique associated with improved recovery following prostate cancer surgery. Through both his surgical practice and academic research, he continues to contribute to the development of modern approaches that aim to improve patient outcomes.
He was recognised as one of London’s most influential doctors by the Evening Standard, reflecting his contribution to advancing prostate cancer surgery and patient care.
Why Specialist Expertise Matters
NeuroSAFE is a highly specialised technique that requires far more than advanced technology alone. Its success depends on the expertise of both the robotic surgeon and the specialist pathology team, working together to interpret real-time findings and apply them appropriately during the operation. This collaborative approach helps ensure that important surgical decisions are based on the most up-to-date information available, supporting the best possible balance between effective treatment of prostate cancer and the preservation of urinary continence and erectile function where clinically appropriate.
Professor Prasanna Sooriakumaran is internationally recognised for his expertise in robotic prostate cancer surgery and advanced nerve-preservation techniques. He performs the highest number of complex and salvage robotic prostatectomy procedures at University College London Hospital (UCLH), the UK’s highest-volume robotic prostate cancer centre, and employs the latest evidence-based surgical techniques where clinically appropriate to maximise effective treatment of prostate cancer while preserving urinary continence and erectile function wherever possible.
Is NeuroSAFE Right for You?
Whether NeuroSAFE is appropriate depends on the characteristics of your prostate cancer, your MRI and biopsy findings, and your individual circumstances. It also depends on whether the technique is clinically suitable for your cancer and available at the hospital where your surgery is performed.
A consultation with Professor Prasanna Sooriakumaran allows your diagnosis to be reviewed in detail, with clear, specialist guidance on whether NeuroSAFE may form part of your surgical treatment plan and the most appropriate approach to achieving the best possible outcome.
Book Your Consultation
If you have been diagnosed with prostate cancer and would like to understand whether NeuroSAFE may be appropriate for your treatment, a consultation with Professor Prasanna Sooriakumaran provides a detailed review of your diagnosis, MRI findings, biopsy results, and treatment options, with clear specialist guidance on whether NeuroSAFE may form part of the most appropriate surgical approach for your individual circumstances.
Book Your Consultation
If you have been diagnosed with prostate cancer and would like to understand whether NeuroSAFE may be appropriate for your treatment, a consultation with Professor Prasanna Sooriakumaran provides a detailed review of your diagnosis, MRI findings, biopsy results, and treatment options, with clear specialist guidance on whether NeuroSAFE may form part of the most appropriate surgical approach for your individual circumstances.
Frequently Asked Questions
What is NeuroSAFE?
NeuroSAFE is an advanced technique used during robotic prostate surgery that provides real-time pathological assessment to help determine whether the nerves surrounding the prostate can be safely preserved.
Does every patient have NeuroSAFE?
No. NeuroSAFE is only used where it is clinically appropriate and where the necessary specialist pathology facilities are available.
Does NeuroSAFE improve erectile function?
For selected patients, NeuroSAFE may increase the opportunity for preserving the nerves responsible for erectile function while maintaining effective cancer treatment. However, outcomes depend on several factors, including age, pre-existing function, and the characteristics of the cancer.
Is NeuroSAFE an alternative to robotic surgery?
No. NeuroSAFE is not a separate treatment. It is an advanced technique that may be used during robotic prostate surgery where appropriate.
Why should I choose a surgeon experienced in NeuroSAFE?
NeuroSAFE requires a high level of surgical expertise and close collaboration with a specialist pathology team. An experienced robotic prostate surgeon can determine when the technique is appropriate and integrate the findings into the operation to help achieve the best possible balance between effective cancer treatment and preservation of urinary continence and erectile function.
Why should I seek a second opinion before prostate surgery?
Prostate cancer surgery is a major decision, and many men find reassurance in obtaining an expert opinion before proceeding. A specialist review can help confirm whether surgery is the most appropriate treatment option, explain the advantages and considerations of different approaches, and ensure that you feel fully informed and confident about your decision.
Is NeuroSAFE suitable for everyone undergoing robotic prostate surgery?
No. NeuroSAFE is only suitable for selected patients. Whether it is appropriate depends on the characteristics of your cancer, your MRI and biopsy findings, and the availability of the specialist pathology facilities required to perform the technique.
Does NeuroSAFE guarantee preservation of erectile function?
No. NeuroSAFE does not guarantee the preservation of erectile function. However, for suitable patients, it may increase the opportunity for safe nerve preservation while maintaining effective treatment of prostate cancer. Outcomes also depend on factors such as age, pre-existing erectile function, and the location and extent of the cancer.
Does NeuroSAFE make prostate cancer surgery more effective?
NeuroSAFE provides additional information during surgery to help guide important surgical decisions. This may enable a more precise balance between effective treatment of prostate cancer and preserving the nerves responsible for erectile function where it is safe to do so.
Is NeuroSAFE available at every hospital?
No. NeuroSAFE requires specialist frozen-section pathology facilities and an experienced pathology team, so it is not available at every hospital. Professor Prasanna Sooriakumaran will advise whether the technique is available and appropriate for your individual treatment.
How will I know if NeuroSAFE is right for me?
The suitability of NeuroSAFE can only be determined after a detailed review of your diagnosis, including your PSA level, MRI findings, biopsy results, and the characteristics of your cancer. During your consultation, Professor Prasanna Sooriakumaran will explain whether NeuroSAFE may form part of the most appropriate surgical approach for your individual circumstances.
Leadership Roles
Professor Prasanna Sooriakumaran is always looking to grow, innovate, and improve patient care for urology and prostate cancer patients in every possible way. To achieve this, he has secured several other prestigious leadership roles.
Urological innovation
Chief Men’s Health Officer
Chief Academic Officer
Lead Medical Advisor in Men’s Health
Research Physician
Lead for Urology and Men’s Health
Clinical Lead for Robotic Soft-Tissue Surgery
Invited Reviewer
Leading a £3 Million Prostate Cancer Surgery Trial at the University of Oxford
Professor Prasanna Sooriakumaran is actively advancing the field of prostate cancer surgery through his academic and clinical research. He is leading a landmark prostate cancer surgery trial supported by a £3 million Department of Health and Social Care grant at the University of Oxford.
This major research initiative is focused on improving surgical techniques and patient outcomes, reflecting a commitment not only to delivering high-quality care today, but also to shaping the future of prostate cancer treatment.
Through his ongoing work in research and innovation, Professor Prasanna Sooriakumaran remains at the forefront of developments in prostate cancer surgery, ensuring patients benefit from the most advanced and evidence-based approaches available.
Appointed to Establish Mayo Clinic’s Urology & Prostate Services in London
Patient Experiences
Read all of Professor Prasanna Sooriakumaran’s patient reviews at Doctify.
Professor Prasanna Sooriakumaran Performs the Highest Number of Complex and Salvage Prostate Cancer Surgeries at UCLH
University College London Hospital (UCLH) is the UK’s highest-volume robotic prostate cancer centre. Due to his world-leading expertise in prostate cancer surgery, Professor Prasanna Sooriakumaran performs the highest number of complex and salvage robotic prostatectomy procedures at UCLH. He is also the only UCLH prostate surgeon to have been recognised by both the Daily Mail and the Evening Standard for his expertise in prostate cancer surgery, reflecting the high level of complex cases referred to him from across the UK and internationally.
Consultation Locations
Professor Prasanna Sooriakumaran practises as a robotic prostate cancer surgeon within the NHS at one of the UK’s highest-volume centres. He also sees private patients at leading private hospitals across London, providing access to high-quality facilities and specialist care.